Filter posts

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Is 2014 a good time to invest in biotech? How many biotech IPOs will there …

Cheerios Labeling “Has Emboldened, Not Appeased, Anti-technology Activists”

There continues to be buzz in the media over General Mills’s January 2 announcement to …

Join BIO and Fuels America in Voicing Support for the RFS

The Only Existing Transportation Fuel Program to Tackle Climate Change Is in Danger The Fuels …

Young Invincibles Still Need Flu Shot

Last Friday, the CDC reported that 35 states are seeing widespread cases of influenza. Young …

What’s In Store for Biotechs at this Year’s CEO & Investor Conference

In just a few weeks, industry leaders will gather in New York for one of …

Congress Passes Omnibus Spending Agreement

This week, BIO President and CEO Jim Greenwood praised the Congress for passing the fundingbill …

Bioscience’s Bright Spots

According to Business Xpansion Journal, biotech is still big business and partnerships lead to profit. And BIO …

GMO Opposition Creates Uncertainty for Farmers!

Dr. Cathleen Enright, BIO’s Executive Vice President for Food and Agriculture, recently presented at the …

Couldn’t Make it to San Francisco This Week?

Me neither, so here is what I am reading for updates about the 32nd Annual JPMorgan Healthcare …

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry

Innovative biotech companies at all stages of the development process are working toward next generation …